Category Archives: Nano medicine

Nanorobotic is a new technology of robot engineering. The development of nano-robot belongs to molecular nanotechnology

Nanorobotic Marketreport offers a comprehensive valuation of the marketplace. It does so via in-depth comprehensions, grateful market growth by pursuing past developments, and studying the present situation and future forecasts based on progressive and likely areas. Each research report supports as a depository of analysis and data for each and every side of the industry, including but not limited to: Regional markets, types, applications, technology developments and the competitive landscape.

The Nanorobotic Market report profiles the following companies, which includes: Bruker, Jeol, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, Ev Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract, Nanonics Imaging

Get Sample Copy of this Report at @https://www.reportsintellect.com/sample-request/581106

Report Description:-

This report presents a comprehensive overview, market shares and growth opportunities of Nanorobotic market by product type, application, key companies and key regions.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Product Type Coverage:-Nanomanipulator, Bio-Nanorobotic, Magnetically Guided Robot

Product Application Coverage:-Nanometer Medicine, Biomedical, Machine, Other

Market Segment by Regions, regional analysis coversNorth America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Colombia etc.)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Get 10% Discount on ThisReport@https://www.reportsintellect.com/discount-request/581106

Table of Content:

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered1.4 Market Analysis by Type1.5 Market by Application1.6 Study Objectives1.7 Years Considered

2 Global Growth Trends2.1 Nanorobotic- Market Size2.2 Nanorobotic- Growth Trends by Regions2.3 Industry Trends

3 Market Share by Key Players3.1 Nanorobotic- Market Size by Manufacturers3.2 Nanorobotic- Key Players Head office and Area Served3.3 Key Players Nanorobotic- Product/Solution/Service3.4 Date of Enter into Nanorobotic- Market3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product4.1 Global Nanorobotic- Sales by Product4.2 Global Nanorobotic- Revenue by Product4.3 Nanorobotic- Price by Product

5 Breakdown Data by End User5.1 Overview5.2 Global Nanorobotic- Breakdown Data by End User

Research objectives

About Us:-Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in todays competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you.

So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact Us:

Sales@reportsintellect.comPH + 1-706-996-2927US Address:225 Peachtree Street NE,Suite 400,Atlanta, GA 30303

More here:
Nanorobotic Market 2019 Technological Perspective, Latest Trends and key manufacturers:: Bruker, Jeol, Thermo Fisher Scientific, Ginkgo Bioworks -...

Marine Le Goas,1 Marie Paquet,25 Aurlie Paquirissamy,1 Julien Guglielmi,24 Cathy Compin,24 Juliette Thariat,6 Georges Vassaux,24 Valrie Geertsen,1 Olivier Humbert,25 Jean-Philippe Renault,1 Graldine Carrot,1 Thierry Pourcher,24 Batrice Cambien24

1NIMBE, Commissariat lEnergie Atomique, Centre National Recherche Scientifique UMR 3685, Universit Paris-Saclay, Gif-sur-Yvette, France; 2Laboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), Institut de Biosciences et Biotechnologies dAix-Marseille (BIAM), Commissariat lEnergie Atomique, Nice, France; 3Laboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), University Nice Sophia Antipolis, Nice, France; 4Laboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), University Cte dAzur, Nice, France; 5Nuclear Medicine Department, Centre Antoine Lacassagne, Nice, France; 6Department of Radiation Oncology, Centre Franois Baclesse, Universit de Normandie, Caen, France

Correspondence: Batrice CambienLaboratory Transporter in Imaging and Radiotherapy in Oncology (TIRO), University Nice Sophia Antipolis, 28 Avenue Valombrose, Nice Cedex 2 06107, FranceTel +33 493 377 715Email cambien@unice.fr

Background: Human trials combining external radiotherapy (RT) and metallic nanoparticles are currently underway in cancer patients. For internal RT, in which a radioisotope such as radioiodine is systemically administered into patients, there is also a need for enhancing treatment efficacy, decreasing radiation-induced side effects and overcoming radio-resistance. However, if strategies vectorising radioiodine through nanocarriers have been documented, sensitizing the neoplasm through the use of nanotherapeutics easily translatable to the clinic in combination with the standard systemic radioiodine treatment has not been assessed yet.Method and materials: The present study explored the potential of hybrid poly(methacrylic acid)-grafted gold nanoparticles to improve the performances of systemic 131I-mediated RT on cancer cells and in tumor-bearing mice. Such nanoparticles were chosen based on their ability previously described by our group to safely withstand irradiation doses while exhibiting good biocompatibility and enhanced cellular uptake.Results: In vitro clonogenic assays performed on melanoma and colorectal cancer cells showed that poly(methacrylic acid)-grafted gold nanoparticles (PMAA-AuNPs) could efficiently lead to a marked tumor cell mortality when combined to a low activity of radioiodine, which alone appeared to be essentially ineffective on tumor cells. In vivo, tumor enrichment with PMAA-AuNPs significantly enhanced the killing potential of a systemic radioiodine treatment.Conclusion: This is the first report of a simple and reliable nanomedicine-based approach to reduce the dose of radioiodine required to reach curability. In addition, these results open up novel perspectives for using high-Z metallic NPs in additional molecular radiation therapy demonstrating heterogeneous dose distributions.

Keywords: internal radioisotope therapy, radioiodine, polymer-grafted gold nanoparticles, melanoma, colorectal cancer, radio-enhancement

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Link:
Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nano | IJN - Dove Medical Press

Han Liao,1,2 Shan Zhao,1,2 Huihui Wang,1,2 Yang Liu,1 Ying Zhang,1 Guangwei Sun1

1Scientific Research Center for Translational Medicine, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, Peoples Republic of China; 2University of Chinese Academy of Sciences, Beijing 100049, Peoples Republic of China

Correspondence: Guangwei SunScientific Research Center for Translational Medicine, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, Peoples Republic of ChinaTel/Fax +86-411-82463027Email sungw@dicp.ac.cn

Background: Amphiphilic fusion drugs are covalent conjugates of a lipophilic drug and a hydrophilic drug or their active fragments. These carrier-free self-assembly nanomaterials are helpful to co-deliver two synergic drugs to the same site regardless of pharmacokinetic properties of individual drugs. Retinoic hydroxamic acid (RHA) is a fusion drug of all-trans retinoic acid (ATRA) and vorinostat, a histone deacetylase (HDAC) inhibitor showing synergic effect with ATRA on cancer therapy. Although RHA was synthesized in 2005, its nanoscale self-assembly property, anticancer activity, and possible related mechanism are still unclear.Methods: RHA nanoparticles were observed under transmission electron microscope (TEM). Both in vitro cell viability, colony formation assay, and in vivo xenograft mouse tumor model were employed here to study anticancer activity of RHA nanoparticles. The putative synergic anticancer mechanism of activating retinoic acid receptor (RAR) and inhibiting HDAC were investigated via receptor inhibitor rescue assay and in vitro enzyme activity assay, respectively.Results: RHA could form nanoparticle formation by self-assembly and abrogates growth of several solid tumor cell lines even after RHA nanoparticles washout. However, opposite to our initial hypothesis, pre-treating the melanoma cells with RAR antagonists showed no impact on inhibitory effect of RHA nanoparticles, which suggested that the target of the molecule on melanoma cells is not RAR and retinoid X receptor (RXR). Importantly, RHA nanoparticles inhibited the growth of xenograft tumors without obvious impact on haematological indexes and hepatorenal function of these tumor-bearing mice.Conclusion: Our findings demonstrate the promise of RHA nanoparticles in treating malignant melanoma tumors with high efficacy and low toxicity.

Keywords: nano-drugs, self-assembly, retinoid, cancer therapy, melanoma

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more:
Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy | IJN - Dove Medical Press

Nanotechnology is one of the most promising technologies in 21st century. Nanotechnology is a term used when technological developments occur at 0.1 to 100 nm scale. Nano medicine is a branch of nanotechnology which involves medicine development at molecular scale for diagnosis, prevention, treatment of diseases and even regeneration of tissues and organs. Thus it helps to preserve and improve human health. Nanomedicine offers an impressive solution for various life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, orthopedic problems, diseases related to blood, lungs, neurological, and cardiovascular system.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/6370

Development of a new nenomedicine takes several years which are based on various technologies such as dendrimers, micelles, nanocrystals, fullerenes, virosome nanoparticles, nanopores, liposomes, nanorods, nanoemulsions, quantum dots, and nanorobots.

In the field of diagnosis, nanotechnology based methods are more precise, reliable and require minimum amount of biological sample which avoid considerable reduction in consumption of reagents and disposables. Apart from diagnosis, nanotechnology is more widely used in drug delivery purpose due to nanoscale particles with larger surface to volume ratio than micro and macro size particle responsible for higher drug loading. Nano size products allow to enter into body cavities for diagnosis or treatment with minimum invasiveness and increased bioavailability. This will not only improve the efficacy of treatment and diagnosis, but also reduces the side effects of drugs in case of targeted therapy.

Global nanomedicine market is majorly segmented on the basis of applications in medicines, targeted disease and geography. Applications segment includes drug delivery (carrier), drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging. Global nanomedicine divided on the basis of targeted diseases or disorders in following segment: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Geographically, nanomedicine market is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Considering nanomedicine market by application, drug delivery contribute higher followed by in-vitro diagnostics. Global nanomedicine market was dominated by oncology segment in 2012 due to ability of nanomedicine to cross body barriers and targeted to tumors specifically however cardiovascular nanomedicine market is fastest growing segment. Geographically, North America dominated the market in 2013 and is expected to maintain its position in the near future. Asia Pacific market is anticipated to grow at faster rate due to rapid increase in geriatric population and rising awareness regarding health care. Europe is expected to grow at faster rate than North America due to extensive product pipeline portfolio and constantly improving regulatory framework.

Major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, market entry of new companies is expected to bridge the gap between supply and demand of nanomedicines. Above mentioned drivers currently outweigh the risk associated with nanomedicines such as toxicity and high cost. At present, cancer is one of the major targeted areas in which nanomedicines have made contribution. Doxil, Depocyt, Abraxane, Oncospar, and Neulasta are some of the examples of pharmaceuticals formulated using nanotechnology.

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Request to Browse Full Table of Content, figure and Tables @https://www.persistencemarketresearch.com/toc/6370

Key geographies evaluated in this report are:

Key features of this report

See the original post here:
Healthcare Nanotechnology Nanomedicine Market to Witness a Pronounce Growth During 2019-2029 - Zebvo

Nanotechnology is one of the most promising technologies in 21st century. Nanotechnology is a term used when technological developments occur at 0.1 to 100 nm scale. Nano medicine is a branch of nanotechnology which involves medicine development at molecular scale for diagnosis, prevention, treatment of diseases and even regeneration of tissues and organs. Thus it helps to preserve and improve human health. Nanomedicine offers an impressive solution for various life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, orthopedic problems, diseases related to blood, lungs, neurological, and cardiovascular system.

Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/6370?source=atm

Development of a new nenomedicine takes several years which are based on various technologies such as dendrimers, micelles, nanocrystals, fullerenes, virosome nanoparticles, nanopores, liposomes, nanorods, nanoemulsions, quantum dots, and nanorobots.

In the field of diagnosis, nanotechnology based methods are more precise, reliable and require minimum amount of biological sample which avoid considerable reduction in consumption of reagents and disposables. Apart from diagnosis, nanotechnology is more widely used in drug delivery purpose due to nanoscale particles with larger surface to volume ratio than micro and macro size particle responsible for higher drug loading. Nano size products allow to enter into body cavities for diagnosis or treatment with minimum invasiveness and increased bioavailability. This will not only improve the efficacy of treatment and diagnosis, but also reduces the side effects of drugs in case of targeted therapy.

Request to View TOC at https://www.persistencemarketresearch.com/toc/6370?source=atm

Global nanomedicine market is majorly segmented on the basis of applications in medicines, targeted disease and geography. Applications segment includes drug delivery (carrier), drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging. Global nanomedicine divided on the basis of targeted diseases or disorders in following segment: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Geographically, nanomedicine market is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Considering nanomedicine market by application, drug delivery contribute higher followed by in-vitro diagnostics. Global nanomedicine market was dominated by oncology segment in 2012 due to ability of nanomedicine to cross body barriers and targeted to tumors specifically however cardiovascular nanomedicine market is fastest growing segment. Geographically, North America dominated the market in 2013 and is expected to maintain its position in the near future. Asia Pacific market is anticipated to grow at faster rate due to rapid increase in geriatric population and rising awareness regarding health care. Europe is expected to grow at faster rate than North America due to extensive product pipeline portfolio and constantly improving regulatory framework.

Major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, market entry of new companies is expected to bridge the gap between supply and demand of nanomedicines. Above mentioned drivers currently outweigh the risk associated with nanomedicines such as toxicity and high cost. At present, cancer is one of the major targeted areas in which nanomedicines have made contribution. Doxil, Depocyt, Abraxane, Oncospar, and Neulasta are some of the examples of pharmaceuticals formulated using nanotechnology.

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are: North America U.S Canada Europe France, Germany, Italy, Spain, and the UK Eastern Europe CIS APAC China India Japan Australia Others Latin America Argentina Brazil Others

Key features of this report Drivers, restraints, and challenges shaping the Healthcare Nanotechnology (Nanomedicine) market dynamics Latest innovations and key events in the industry Analysis of business strategies of the top players Healthcare Nanotechnology (Nanomedicine) market estimates and forecasts(2015 -2021)

Get Full Report Access of this report at https://www.persistencemarketresearch.com/checkout/6370?source=atm

View post:
Healthcare Nanotechnology (Nanomedicine) Market Likely To Experience High Revenue Generation In The Forthcoming Years - Commerce Gazette

Indian scientists have found that BCG the worlds only vaccine against TB can be made more effective if nano-particles of curcumin, the main component of the popular kitchen spice turmeric are used in tandem with the shot.

The discovery, scientists say, open up a new window to tackle drug-resistant tuberculosis, one of the worlds biggest public health threats that kills lakhs each year.

Biologists at Jawaharlal Nehru University, Delhi were looking for ways to improve the existing treatment options for TB when they turned their attention to nano-curcumin, an ultra-small version of the wonder chemical that lies at the core of the kitchen spice, known to harbour many medicinal properties.

"We have shown that a booster dose of BCG together with nano-curcumin gives superior vaccine efficacy. This opens up a new area of vaccine research and has huge implications. We are ready for clinical trials," team leader Gobardhan Das from JNU's Special Centre for Molecular Medicine told DH.

Discovered in 1921, BCG is the world's sole TB vaccine, but it only protects children and that too with varying efficacy.

In their experiments aimed at enhancing the vaccines efficiency, the researchers first injected laboratory mice with BCG vaccine and subsequently gave them nano-curcumin shots for 30 days.

The JNU team collaborated with KITT University, Bhubaneswar and Vanderbilt University, Tennessee, the USA to source the nano-curcumin and analyzing the results.

When they measure biochemical parameters to examine the immune responses, they found an improvement in the vaccines efficacy. Nanocurcumin not only creates an environment conducive for priming and activating the cells that fight against the enemy but also enhances the production of two key immune cells that battle with the bacteria.

Curcumin nanoparticles hold promise for enhancing the efficacy of TB vaccines, the team reported in Infection and Immunity, a journal published by American Society for Microbiology.

"This is a significant result with the potential to address a critical unmet need in TB vaccine development, especially when an alternative to BCG vaccine is nowhere on the horizon," said Anand Ranganathan, a JNU scientist and one of the members of the team.

A vaccine candidate that imparts better protection by BCG would mean fewer antibiotics are required, hence would minimize the chances of development of drug-resistance. This study demonstrates that curcumin nano-particles holds promise to enhance the efficacy of BCG vaccines but more experiments are required to further evaluate its safety and efficacy in other animal models, commented Ramandeep Singh, from Translational Health Science and Technology Institute, Faridabad, who researches on TB but not associated with the BCG paper.

With nearly 28 lakh cases, India has the world's highest number of TB cases in 2016 even though the researchers fear that there are lakhs who escape the surveillance net. The infectious disease causes one death every 90 seconds and 12 lakh new infections each year besides an economic burden of nearly $ 340 billion between 2006 and 2014.

See the article here:
TB vaccines with nano-curcumin work wonders - Deccan Herald

Nanotechnology is one of the most promising technologies in 21st century. Nanotechnology is a term used when technological developments occur at 0.1 to 100 nm scale. Nano medicine is a branch of nanotechnology which involves medicine development at molecular scale for diagnosis, prevention, treatment of diseases and even regeneration of tissues and organs. Thus it helps to preserve and improve human health. Nanomedicine offers an impressive solution for various life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, orthopedic problems, diseases related to blood, lungs, neurological, and cardiovascular system.

Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/6370?source=atm

Development of a new nenomedicine takes several years which are based on various technologies such as dendrimers, micelles, nanocrystals, fullerenes, virosome nanoparticles, nanopores, liposomes, nanorods, nanoemulsions, quantum dots, and nanorobots.

In the field of diagnosis, nanotechnology based methods are more precise, reliable and require minimum amount of biological sample which avoid considerable reduction in consumption of reagents and disposables. Apart from diagnosis, nanotechnology is more widely used in drug delivery purpose due to nanoscale particles with larger surface to volume ratio than micro and macro size particle responsible for higher drug loading. Nano size products allow to enter into body cavities for diagnosis or treatment with minimum invasiveness and increased bioavailability. This will not only improve the efficacy of treatment and diagnosis, but also reduces the side effects of drugs in case of targeted therapy.

Request Report Methodology at https://www.persistencemarketresearch.com/methodology/6370?source=atm

Global nanomedicine market is majorly segmented on the basis of applications in medicines, targeted disease and geography. Applications segment includes drug delivery (carrier), drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging. Global nanomedicine divided on the basis of targeted diseases or disorders in following segment: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Geographically, nanomedicine market is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Considering nanomedicine market by application, drug delivery contribute higher followed by in-vitro diagnostics. Global nanomedicine market was dominated by oncology segment in 2012 due to ability of nanomedicine to cross body barriers and targeted to tumors specifically however cardiovascular nanomedicine market is fastest growing segment. Geographically, North America dominated the market in 2013 and is expected to maintain its position in the near future. Asia Pacific market is anticipated to grow at faster rate due to rapid increase in geriatric population and rising awareness regarding health care. Europe is expected to grow at faster rate than North America due to extensive product pipeline portfolio and constantly improving regulatory framework.

Major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, market entry of new companies is expected to bridge the gap between supply and demand of nanomedicines. Above mentioned drivers currently outweigh the risk associated with nanomedicines such as toxicity and high cost. At present, cancer is one of the major targeted areas in which nanomedicines have made contribution. Doxil, Depocyt, Abraxane, Oncospar, and Neulasta are some of the examples of pharmaceuticals formulated using nanotechnology.

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are: North America U.S Canada Europe France, Germany, Italy, Spain, and the UK Eastern Europe CIS APAC China India Japan Australia Others Latin America Argentina Brazil Others

Key features of this report Drivers, restraints, and challenges shaping the Healthcare Nanotechnology (Nanomedicine) market dynamics Latest innovations and key events in the industry Analysis of business strategies of the top players Healthcare Nanotechnology (Nanomedicine) market estimates and forecasts(2015 -2021)

Request to view TOC at https://www.persistencemarketresearch.com/toc/6370?source=atm

Read the original here:
Healthcare Nanotechnology (Nanomedicine) Market to Witness Growth Acceleration During 2015 2021 - Trading Herald

Indian scientists have shown that turmerics yellow ingredient may help enhance the efficacy of the lone standard vaccine against tuberculosis, which is given to all children at birth but is effective only for about a decade.

Researchers at Jawaharlal Nehru University, New Delhi, have carried out studies on mice to demonstrate that curcumin - a molecule extracted from turmeric when encapsulated into tiny nano-particles, can increase the efficacy of the bacille Camille-Guerin (BCG) vaccine.

The protective effect of the BCG vaccine diminishes over time and is lost by the time children turn 10 or 12.

Gobardhan Das, head of the Centre for Molecular Medicine at JNU, and his colleagues have now shown that curcumin nano-particles can enhance the capacity of the BCG vaccine to stimulate the long-term memory of the immune system.

They found that the efficacy of the BCG vaccine was stronger and lasted longer in immunised mice that had also received curcumin nano-particles for 30 days after receiving the vaccines.

They have published their findings in the research journal Infection and Immunity.

When the immunised mice were challenged by a virulent strain of tuberculosis, delivered through aerosols, the bacterial loads in the lungs and spleen were significantly lower in the mice that had also received the curcumin nano-particles.

The JNU studies suggest that the addition of curcumin nano-particles activates two types of cells in the immune system, called Th1 and Th17, which play a key role in the long-term protection against tuberculosis infections.

We need to validate these findings, but if these results are extrapolated to humans, were proposing enhancing the efficacy of, and long-term protection with, BCG vaccines, Das said.

Earlier studies had established that curcumin can influence the immune system in animals and humans.

Our results suggest that nano-curcumin can elongate or stretch the ability of the immune system to recognise the TB bacilli, said Anand Ranganathan, a study team member.

Read more here:
Curcumin hope in TB fight - Telegraph India

Global Functional Polymer Market: An Overview

The global functional polymers market is expected to expand at a healthy growth rate during 2018-2026. The market is witnessing a rising demand for functional polymers, due to their diverse application as catalysts, reagents, protecting groups, and many others. Their additional mechanical stability and functioning reactions are key to end-user industries. Additionally, these polymers can also be molded in physical shapes and for enhancing chemical reactions, thanks to their flexible industrial nature.

Their wide ranging applications include washing agents in agriculture and medicine. Growing demand for dyes is also driving growth for the functional polymer market. Functional polymers offer a wide variety of benefits for coloring hair through properties such as thermal stability, biocompatibility, chemical stability, solvent resistance, and great color fastness. The functional polymer market is also witnessing growth due to functional and surface coatings. Polymer coating provide an added advantage of superior protection and adherence from corrosion. Furthermore, polymers use as a catalyst for a wide variety of chemical reactions in industries are likely to generate considerable growth for the functional polymer market in the near future.

Global Functional Polymer Market: Notable Developments According to a new study, polymer-based Nano medicine can revolutionize the treatment of cancer in the near future. As per the study published in the Journal of American Chemical Society (JACS), polymer and Nano medicine combination results in negligible immunotoxicity and high level of therapeutic performance for cancers. Researchers in the study developed a theranostic supramolecular polymer using -cyclodextrin as the host. This advanced potion delivered superior ant metastasis capability, and antitumor performance. This development can propel the functional polymer market significantly, thanks to a growing number of cancers worldwide. Polymer based techniques are widely being experimented in the medical sector. A recent study has paved way for artificial limbs, guided by light. A new polymer based material mechanism enables shrinking of materials and changes in shape as needed. The study presented at American Chemical Societys national meeting, the researcher said, they can apply the new polymer in any 3D network and turn it into a stimuli-responsive material. Growing research and development activities such as these driven by growing interest in polymers are expected to create significant opportunities for many players in the functional polymer market.

Global Functional Polymer Market: Key Trends

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/functional-polymer-market.html

The global functional polymer market is expected to expand significantly in the near future, thanks to a rising demand for lightweight material. The materials are rising in demand due in automotive and aerospace industries as well. Additionally, increased in medical applications and depleting petrochemical resources are also expected to drive growth for the functional polymer market.

Growth of bio-based functional polymers is also a positive sign for the functional polymer market. These polymers, derived from agricultural feedstock such as potatoes and corn is lowering dependency on petrochemicals through products such as polybutylene succinate (PBS), polyethylene terephthalate (PET), polyethylene (PE), and polypropylene (PP).

Global Functional Polymer Market: Regional Outlook

The global functional polymer market report will be divided into several main regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The functional polymer market is expected to grow significantly in North America due to growing investment in medical breakthroughs, and growing demand in 3D applications. Additionally, rising automotive and defense related applications are also expected to drive growth in Asia Pacific region in the functional polymer market.

Global Functional Polymer Market: Competitive Dynamics

The global functional polymer market is a competitive and fragmented landscape. Increased innovation and low cost initial investments are driving growth for the functional polymer market in many regions. Some key players in the functional polymer market are Schneider Electric, Honeywell, Federal Signal Corporation, WERMA Signaltechnik, Larson Electronics, and Eaton.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=66401&source=atm

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=66401&source=atm

View original post here:
Functional Polymer Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2027 - The Market Plan

Global Nanotechnology in Medical Applications Market: Overview

In the 20th century, developments in the field of nanotechnology and the applications of the technology in pharmaceuticals and medicines have increased significantly. Nanotechnology uses individual molecules, compounds, or atoms in various structures to produce devices and materials with unique characteristics. It works on matter with dimensions that could range from 1 nanometer to 100 nanometer. Nanotechnology has applications in the formation of various types of nano devices and nano materials. Nanomedicine is a signficant application of nanotechnology. Nanotechnology drugs are used in the field of medicine and health. Nanomedicine makes use of nano electronic biosensors and nano materials. It enables improved diagnosis, early detection and prevention, and proper treatment and examination of diseases. Nanomedicine involves interactions between nano devices and bio molecules in extracellular medium as well as inside human cells. Performance and functioning of drugs at a nano scale is varied from the one seen in a micro scale. The use of nanotechnology can improve the detection of the root cause of diseases and treat the damage that has occurred in the human body. The effect of nanomedicine drugs is faster than that of traditional drugs. Nanomedicine drugs can be used to target specific diseases.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/nanotechnology-in-medical-applications-market.html

The invention of nanotechnology has benefitted human health to a large extent. Advancements in nanotechnology can help repair and reproduce damaged tissue of the body. Nanotechnology enables the production of artificially stimulated cells that are used in tissue engineering. This helps in the development of artificial implants or transplantation of organs. Nanorobots can be modified to repair particular diseased cells. They function in the same way as antibodies that aid in the natural healing processes within the body. Nanotechnology has signficant contributions in the field ofstem cell research. Gold nanoparticles are used in the detection of targeted nucleic acids, with their sequence to recognize the treatment. Gold nanoparticles are being tested for use in the treatment of cancer and other serious harmful diseases. Nanotechnology is being used for developing instruments that purity the human blood. Magnetic microparticles aid in the separation of proteins and cells from complex media, thus helps in the examination of infections in diseases such as sepsis.

Global Nanotechnology in Medical Applications Market: Key Trends

The global nanotechnology in medical applications market is expected to expand at a rapid pace in the coming years. Research and development in nanomedicine is expected to drive the market. Moreover, government funding programs specifically for nanotechnology in key regions are expected to augment the market. However, long drawn out product approval processes and high costs of nanotechnology-based medical devices and products are expected to inhibit the growth of the nanotechnology in medical application market from 2018 to 2026.

Request Brochure of this report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62175&source=atm

Global Nanotechnology in Medical Applications Market: Segmentation

The global nanotechnology in medical applications market can be segmented based on product, application, and region. Based on product, the global nanotechnology in medical applications market can be classified into nanoparticles, biochips, medical textiles, implantable materials, active implantable devices, wound dressings, and others. The implantable materials segment can be further divided into dental filling materials and bone restorative materials. The active implantable devices segment can be further divided into cardiac rhythm management devices, hearing aid devices, and retinal implants. The active implantable devices segment is expected to constitute a prominent share of the global nanotechnology in medicine application market. In terms of application, the market can be categorized into drug delivery & therapeutics, diagnostics techniques, and others.

Global Nanotechnology in Medical Applications Market: Regional Analysis

Based on region, the global nanotechnology in medical applications market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is expected to expand at a robust pace, due to an increase in research efforts, rise in geriatric population, and increase in R&D expenditure on nanotechnology in the region.

Global Nanotechnology in Medical Applications Market: Competitive Landscape

Prominent players operating in the global nanotechnology in medical applications market are AstraZeneca, Ablynx, Abraxis BioScience Inc (Celgene Corporation), BioForce Nanosciences, Calando Pharmaceuticals, Inc., Elan (Alkermes), Kereos, Inc, Kleindiek Nanotechnik GmbH, MagForce AG, BlueWillow Biologics, Nanobiotix, Nanocopoeia, LLC., and Transgenex Nanobiotech, Inc.. among others. The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa) The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period. Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=62175&source=atm

Go here to see the original:
Nanotechnology in Medical Applications Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 - Market Forecast